Last update 01 Nov 2024

Natural killer cell therapy(Altor BioScience)

Overview

Basic Info

Drug Type
Immune cell therapy
Synonyms-
Target-
Mechanism
Cell replacements
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Refractory acute myeloid leukemiaRelapsing acute myeloid leukemia
Originator Organization
Altor BioScience Corp.Altor BioScience Corp.
Active Organization-
Inactive Organization
Altor BioScience Corp.Altor BioScience Corp.
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Natural killer cell therapy(Altor BioScience)
NCT01478074 / WithdrawnPhase 1
A Single-center Open-label Phase I Study of ALT-801 for ex Vivo Maturation and in Vivo Retargeting of Haploidentical Natural Killer Cells Delivered Following Fludarabine, Cytarabine, and G-CSF in Patients With Relapsed/Refractory Acute Myeloid Leukemia
100 Clinical Results associated with Natural killer cell therapy(Altor BioScience)
Login to view more data
100 Translational Medicine associated with Natural killer cell therapy(Altor BioScience)
Login to view more data
100 Patents (Medical) associated with Natural killer cell therapy(Altor BioScience)
Login to view more data
100 Deals associated with Natural killer cell therapy(Altor BioScience)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Refractory acute myeloid leukemiaPhase 1
US
Altor BioScience Corp.Altor BioScience Corp.
01 Nov 2011
Relapsing acute myeloid leukemiaPhase 1
US
Altor BioScience Corp.Altor BioScience Corp.
01 Nov 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free